Benzinga - by Lisa Levin, Benzinga Editor. U.S. stock futures traded lower this morning on Tuesday. Here are some big stocks recording losses in today’s pre-market trading session.
- Design Therapeutics, Inc. (NASDAQ: DSGN) shares declined 37.9% to $4.55 in pre-market trading after the company reported second-quarter results and announced initial results from Phase 1 multiple-ascending dose study of DT-216 for the treatment of Friedrich Ataxia.
- Getty Images Holdings, Inc. (NYSE: GETY) declined 18.6% to $3.70 in pre-market trading after the company reported second-quarter earnings.
- Freedom Holding Corp. (NASDAQ: FRHC) fell 12.8% to $66.01 in pre-market trading. Freedom Holding received Nasdaq notification of noncompliance with listing rule 5250(c)(1).
- Sea Limited (NYSE: SE) fell 11.7% to $50.26 in pre-market trading following weaker-than-expected quarterly results.
- Calliditas Therapeutics AB (NASDAQ: CALT) shares fell 7.8% to $18.78 in pre-market trading after the company announced full results from the NefIgArd Phase 3 trial published in The Lancet.
- Kanzhun Limited (NASDAQ: BZ) shares declined 6.8% to $14.70 in pre-market trading.
- Hanryu Holdings, Inc. (NASDAQ: HRYU) shares declined 6.8% to $6.31 in pre-market trading. Hanryu shares gained 45% on Tuesday after the company announced it partnered with SALTLUX for the development of an AI-powered conversational virtual assistant on K-culture fandom application.
- Discover Financial Services (NYSE: DFS) shares fell 5.8% to $96.62 in pre-market trading after it disclosed the resignation of Roger C. Hochschild as Chief Executive Officer (CEO) and President.
- Hilltop Holdings Inc. (NYSE: HTH) fell 5.6% to $29.31 in pre-market trading.
- Vornado Realty Trust (NYSE: VNO) fell 5.4% to $21.10 in pre-market trading.
- Gol Linhas Aéreas Inteligentes S.A. (NYSE: GOL) fell 5.4% to $3.51 in pre-market trading.
Now Read This: Investor Optimism Falls Further Ahead Of Economic Reports
Don’t forget to check out our premarket coverage here
© 2023 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.